Skip to main content

Table 2 Univariate analysis of the overall survival in these group gastric cancer patients with peritoneal dissemination

From: Body mass index (BMI) may be a prognostic factor for gastric cancer with peritoneal dissemination

Variables

n

1-year survival rate (%)

Median survival (months)

p value

All 518 gastric cancer patients with peritoneal dissemination

 Palliative gastrectomy

   

<0.001

  With

330

19

7.33

 

  Without

188

31

16.13

 

 Tumor size

   

<0.001

  <5 cm

188

31

17.30

 

  5 and <10 cm

243

26

11.00

 

  >10 cm

87

18

9.30

 

 Tumor location

   

0.011

  Upper

118

23

12.00

 

  Middle

105

30

15.60

 

  Lower

191

39

13.33

 

  Total

104

20

8.97

 

 Peritoneal seeding grade

   

<0.001

  P1

136

34

18.67

 

  P2

149

31

15.48

 

  P3

233

19

8.97

 

 Ascite

   

0.001

  With

207

20

9.87

 

  Without

311

31

14.27

 

 Serum CEA level (ng/ml)

   

0.002

  Normal

349

29

14.03

 

  Elevated

142

20

9.33

 

 Serum CA19-9 level (U/ml)

   

0.033

  Normal

314

29

13.53

 

  Elevated

169

22

11.27

 

 Palliative chemotherapy

   

<0.001

  Yes

337

35

17.40

 

  No

181

9

6.90

 

 BMI group (kg/m2)

   

<0.001

  <18.5

167

15

8.17

 

  18.5–23

232

35

18.67

 

  >23

119

25

11.87